
Rinovum Women's Health
closedDeveloper of medical devices that aid natural fertility and conception.
Date | Investors | Amount | Round |
---|---|---|---|
- | investor investor | €0.0 | round |
investor | €0.0 | round | |
investor | €0.0 | round | |
N/A | €0.0 | round | |
N/A | €0.0 | round | |
investor investor | €0.0 | round | |
N/A | €0.0 | round | |
$6.0m | Series C | ||
Total Funding | 000k |
Related Content
Rinovum Women's Health, LLC is a privately held health company focused on developing and marketing innovative, home-use medical devices aimed at enhancing lives and empowering individuals to take charge of their health. The company operates primarily in the women's health market, offering products that address common yet often overlooked issues such as stress urinary incontinence (SUI) and fertility challenges.
Rinovum's flagship products include the Stork OTC, an FDA-cleared home conception aid that provides a cost-effective alternative to expensive clinical fertility treatments, and Revive, a reusable bladder support device designed to reduce leakage from SUI. Both products are available over-the-counter and can be purchased at select retailers across the United States.
The company's business model revolves around the direct-to-consumer sales of these medical devices, leveraging partnerships with retail chains to ensure broad market availability. Revenue is generated through product sales, with a focus on affordability and ease of use to attract a wide range of customers.
Rinovum's target clients include women seeking non-invasive, drug-free solutions for fertility and urinary incontinence, as well as healthcare providers looking for effective, at-home treatment options for their patients.
Keywords: women's health, home-use devices, fertility aid, stress urinary incontinence, FDA-cleared, cost-effective, direct-to-consumer, reusable bladder support, non-invasive, over-the-counter.